HOSPITAL FOR SPECIAL SURGERY
- Type
- Teaching hospital
- Where
- Paramus, NJ
- Medicare CCN
- 330270
- Received
- $8,217,471 in 367 records, 2019 ($6,180,453 general, $2,037,017 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 186 | $6,180,453 |
| 2019 | Research payment | 181 | $2,037,017 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Current or prospective ownership or investment interest | 1 | $3,525,911 |
| Research payment | 181 | $2,037,017 |
| Royalty or License | 20 | $1,797,936 |
| Grant | 61 | $417,669 |
| Space rental or facility fees (teaching hospital only) | 42 | $178,063 |
| Consulting Fee | 11 | $163,430 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 30 | $68,075 |
| Education | 4 | $19,017 |
| Gift | 5 | $6,297 |
| Charitable Contribution | 4 | $3,500 |
| Food and Beverage | 8 | $551 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | EXACTECH, INC. | $449,118 | Royalty or License | Cash or cash equivalent | OPTETRAK Device, ORTHOPAEDIC | 2019 | |
| 2019-12-31 | AstraZeneca UK Limited | $14,408 | Research payment | In-kind items and services | The purpose of this study is to characterise longterm safety and tolerability of intravenous anifrolumab A Multicentre R | 2019 | |
| 2019-12-31 | Stryker Corporation | $6,070 | Gift | Cash or cash equivalent | NONE Device, NONE | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $57 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-31 | Stryker Corporation | $50 | Gift | Cash or cash equivalent | NONE Device, NONE | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $0 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-30 | Medical Device Business Services, Inc. | $4,777 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-12-30 | Medical Device Business Services, Inc. | $3,766 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-12-30 | Medical Device Business Services, Inc. | $3,393 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-12-26 | Stryker Corporation | $8,671 | Research payment | Cash or cash equivalent | MAKO Device, KNEES, HIPS | ALIGNMENT AND CLINICAL OUTCOMES OF ROBOTIC ARM ASSISTED TOTAL KNEE ARTHROPLASTY | 2019 |
| 2019-12-26 | Stryker Corporation | $3,334 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MAKO Device, KNEES, HIPS | 2019 | |
| 2019-12-24 | KCI USA, Inc. | $4,225 | Research payment | Cash or cash equivalent | PREVENA Device, NON-COVERED | KCI.PREVENA.2017.01 Post-market, Randomized, Open-Label, Multicenter, Study to Evaluate the Effectiveness of Closed Inci | 2019 |
| 2019-12-23 | Medical Device Business Services, Inc. | $2,625 | Research payment | Cash or cash equivalent | EXTERNAL FIXATION Device, Trauma | Data Access Agreement for clinical data on Patellar Fixation following a fracture | 2019 |
| 2019-12-20 | UOC USA INC | $4,400 | Consulting Fee | Cash or cash equivalent | U-Motion II Device, UOC Hip System | 2019 | |
| 2019-12-19 | Stryker Corporation | $21,920 | Research payment | Cash or cash equivalent | REJUVENATE Device, HIPS | CLINICAL AND RADIOGRAPHIC OUTCOME OF THE STRYKER REJUVENATE MODULAR STEMS | 2019 |
| 2019-12-17 | Smith+Nephew, Inc. | $11,675 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Q-Fix Device, Sports Med Hip | 2019 | |
| 2019-12-17 | Orthofix Medical, Inc. | $1,434 | Research payment | Cash or cash equivalent | M6-C Artificial Cervical Disc Device, PROSTHESIS, INTERVERTEBRAL DISC | M6-C IDE | 2019 |
| 2019-12-13 | Zimmer Biomet Holdings, Inc. | $10,000 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-12-13 | TriMed, Inc. | $4,582 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-12-12 | Joint Restoration Foundation, Inc. | $20,927 | Research payment | Cash or cash equivalent | Evaluation of a Bone-ACL-Bone Graft for ACL Reconstruction | 2019 | |
| 2019-12-12 | Ortho Development Corporation | $1,247 | Royalty or License | Cash or cash equivalent | Spinal Rod Device, ORTHOPEDIC DEVICE | 2019 | |
| 2019-12-11 | GE HEALTHCARE | $25,000 | Research payment | Cash or cash equivalent | Device, X-RAY | ASSESSMENT OF RISK FACTORS AND INTERVENTION STRATEGIES FOR FIFTH METATARSAL STRESS FRACTURES | 2019 |
| 2019-12-11 | Medical Device Business Services, Inc. | $10,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-11 | Smith+Nephew, Inc. | $250 | Research payment | Cash or cash equivalent | Journey II XR Device, Recon Knees | A Prospective Multicenter, Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the Journey | 2019 |
| 2019-12-10 | EXACTECH, INC. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OPTETRAK Device, ORTHOPAEDIC | 2019 | |
| 2019-12-05 | Stryker Corporation | $10,016 | Research payment | Cash or cash equivalent | T2 Device, TRAUMA & EXTREMETIES | MAVRIC MRI USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIDENT II TRITANIUM SYSTEM | 2019 |
| 2019-12-05 | EXACTECH, INC. | $7,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NOVATION HIP Device, ORTHOPAEDIC | 2019 | |
| 2019-12-05 | Teva Pharmaceuticals USA, Inc. | $814 | Research payment | Cash or cash equivalent | Ajovy Drug, Central Nervous System | A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double Blind, Placebo Controlled, Parallel Group Study, Including | 2019 |
| 2019-11-26 | Smith+Nephew, Inc. | $15,750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-11-25 | Pacira Therapeutics, Inc. | $5,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Zilretta Drug, Musculoskeletal | 2019 | |
| 2019-11-25 | Smith+Nephew, Inc. | $1,560 | Research payment | Cash or cash equivalent | Birmingham Hip Resurfacing Device, Recon Hips | Birmingham Hip Resurfacing System BHR Post Approval Study US | 2019 |
| 2019-11-21 | Radius Health, Inc. | $60,075 | Research payment | Cash or cash equivalent | Phase II Trial of Abaloparatide vs Placebo - Spinal Fusion - Phase II Trial of Abaloparatide vs Placebo in Post-Menopaus | 2019 | |
| 2019-11-21 | Radius Health, Inc. | $60,075 | Research payment | Cash or cash equivalent | Phase II Trial of Abaloparatide vs Placebo - Spinal Fusion - Phase II Trial of Abaloparatide vs Placebo in Post-Menopaus | 2019 | |
| 2019-11-21 | BioFire Diagnostics, LLC | $9,000 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-11-21 | PFIZER INC. | $7,816 | Research payment | Cash or cash equivalent | A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 | 2019 | |
| 2019-11-21 | Stryker Corporation | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MAKO Device, KNEES, HIPS | 2019 | |
| 2019-11-20 | Medical Device Business Services, Inc. | $300 | Research payment | Cash or cash equivalent | ACTIS Device, Ortho-Hip | Actis Total Hip System 2 Year Follow-up | 2019 |
| 2019-11-18 | Lima USA, Inc. | $11,319 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Promade Device, Devices | 2019 | |
| 2019-11-18 | Medical Device Business Services, Inc. | $7,962 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-11-18 | Medical Device Business Services, Inc. | $4,127 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-11-18 | Medical Device Business Services, Inc. | $3,835 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-11-18 | Medical Device Business Services, Inc. | $3,685 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-11-18 | Medical Device Business Services, Inc. | $3,393 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-11-18 | Medical Device Business Services, Inc. | $3,393 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-11-14 | Joint Restoration Foundation, Inc. | $41,855 | Research payment | Cash or cash equivalent | Evaluation of a Bone-ACL-Bone Graft for ACL Reconstruction | 2019 | |
| 2019-11-14 | Ortho Development Corporation | $876 | Royalty or License | Cash or cash equivalent | Spinal Rod Device, ORTHOPEDIC DEVICE | 2019 | |
| 2019-11-14 | Zimmer Biomet Holdings, Inc. | $66 | Food and Beverage | In-kind items and services | Persona Revision Device, Knees | 2019 | |
| 2019-11-14 | Zimmer Biomet Holdings, Inc. | $57 | Food and Beverage | In-kind items and services | Persona Revision Device, Knees | 2019 | |
| 2019-11-13 | Intellijoint Surgical Inc. | $12,921 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Intellijoint HIP Device, Orthopedics | 2019 | |
| 2019-11-13 | Orion Corporation | $6,210 | Research payment | Cash or cash equivalent | Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS | 2019 | |
| 2019-11-13 | Teva Pharmaceuticals USA, Inc. | $2,648 | Research payment | Cash or cash equivalent | Ajovy Drug, Central Nervous System | A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double Blind, Placebo Controlled, Parallel Group Study, Including | 2019 |
| 2019-11-13 | Teva Pharmaceuticals USA, Inc. | $750 | Research payment | Cash or cash equivalent | Ajovy Drug, Central Nervous System | A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double Blind, Placebo Controlled, Parallel Group Study, Including | 2019 |
| 2019-11-12 | BioFire Diagnostics, LLC | $8 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-11-11 | Smith+Nephew, Inc. | $56,755 | Research payment | Cash or cash equivalent | REDAPT Revision Hip System Device, Recon Hips | REDAPT 17 Monolithic Stems | 2019 |
| 2019-11-11 | Smith+Nephew, Inc. | $17,278 | Research payment | Cash or cash equivalent | Oxinium Hips Device, Recon Hips | A Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub | 2019 |
| 2019-11-11 | Cumberland Pharmaceuticals, Inc. | $8,550 | Research payment | Cash or cash equivalent | CPI-IFE -004 SSc | 2019 | |
| 2019-11-11 | Zimmer Biomet Holdings, Inc. | $53 | Food and Beverage | In-kind items and services | Persona Revision Device, Knees | 2019 | |
| 2019-11-07 | Stryker Corporation | $3,794 | Research payment | Cash or cash equivalent | SECUR-FIT Device, HIPS | SECURFIT ADVANCED OUTCOMES STUDY | 2019 |
| 2019-11-07 | Smith+Nephew, Inc. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Navio Surgical System Device, Recon Robotics | 2019 | |
| 2019-11-07 | Smith+Nephew, Inc. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Birmingham Hip Resurfacing Device, Recon Hips | 2019 | |
| 2019-11-07 | Zimmer Biomet Holdings, Inc. | $44 | Food and Beverage | In-kind items and services | Juggerstitch Device, Sports Medicine | 2019 | |
| 2019-11-06 | Abbott Laboratories | $316 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-11-06 | BioFire Diagnostics, LLC | $184 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-31 | Zimmer Biomet Holdings, Inc. | $119 | Food and Beverage | In-kind items and services | Stratum Foot Plating System Device, Foot & Ankle | 2019 | |
| 2019-10-31 | Zimmer Biomet Holdings, Inc. | $104 | Food and Beverage | In-kind items and services | Stratum Foot Plating System Device, Foot & Ankle | 2019 | |
| 2019-10-31 | Zimmer Biomet Holdings, Inc. | $53 | Food and Beverage | In-kind items and services | Juggerstitch Device, Sports Medicine | 2019 | |
| 2019-10-31 | Zimmer Biomet Holdings, Inc. | $52 | Food and Beverage | In-kind items and services | Juggerstitch Device, Sports Medicine | 2019 | |
| 2019-10-30 | Stryker Corporation | $3,374 | Research payment | Cash or cash equivalent | TRITANIUM Device, HIPS | TRIDENT II TRITANIUM OUTCOMES STUDY | 2019 |
| 2019-10-29 | Zimmer Biomet Holdings, Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-10-29 | EXACTECH, INC. | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NOVATION HIP Device, ORTHOPAEDIC | 2019 | |
| 2019-10-24 | Stryker Corporation | $12,508 | Research payment | Cash or cash equivalent | RESTORIS Device, HIPS | OUTCOMES OF ROBOTIC ASSISTED UNICOMPARTMENTAL KNEE ARTHROPLASTY, A LARGE SINGLE CENTER STUDY | 2019 |
| 2019-10-24 | EXACTECH, INC. | $5,000 | Grant | Cash or cash equivalent | EQUINOXE Device, ORTHOPAEDIC | 2019 | |
| 2019-10-24 | Smith+Nephew, Inc. | $540 | Research payment | Cash or cash equivalent | Birmingham Hip Resurfacing Device, Recon Hips | Birmingham Hip Resurfacing System BHR Post Approval Study US | 2019 |
| 2019-10-23 | UOC USA INC | $5,614 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CONFORMITY Device, UOC Hip System | 2019 | |
| 2019-10-23 | E.R. Squibb & Sons, L.L.C. | $4,181 | Research payment | Cash or cash equivalent | ORENCIA Biological, Immunology | Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy | 2019 |
| 2019-10-22 | Synthes GmbH | $32,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-10-22 | Synthes GmbH | $7,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-10-22 | Medical Device Business Services, Inc. | $3,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-10-22 | BioFire Diagnostics, LLC | $79 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-21 | Paragon 28, Inc. | $3,777 | Research payment | In-kind items and services | Modeling Adult-Acquired Flatfoot Deformity and Surgical Reconstruction via Osteotomy in a Robotic Gait Simulator | 2019 | |
| 2019-10-18 | BioFire Diagnostics, LLC | $4,207 | Research payment | Cash or cash equivalent | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-17 | Stryker Corporation | $21,920 | Research payment | Cash or cash equivalent | REJUVENATE Device, HIPS | CLINICAL AND RADIOGRAPHIC OUTCOME OF THE STRYKER REJUVENATE MODULAR STEMS | 2019 |
| 2019-10-17 | Stryker Corporation | $10,960 | Research payment | Cash or cash equivalent | REJUVENATE Device, HIPS | CLINICAL AND RADIOGRAPHIC OUTCOME OF THE STRYKER REJUVENATE MODULAR STEMS | 2019 |
| 2019-10-17 | Stryker Corporation | $10,960 | Research payment | Cash or cash equivalent | REJUVENATE Device, HIPS | CLINICAL AND RADIOGRAPHIC OUTCOME OF THE STRYKER REJUVENATE MODULAR STEMS | 2019 |
| 2019-10-16 | Fidia Pharma USA Inc. | $2,959 | Research payment | Cash or cash equivalent | Hymovis Device, Osteoarthritis | EQE7-16-01 | 2019 |
| 2019-10-15 | Ortho Development Corporation | $838 | Royalty or License | Cash or cash equivalent | Spinal Rod Device, ORTHOPEDIC DEVICE | 2019 | |
| 2019-10-10 | BioFire Diagnostics, LLC | $9,451 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-10 | Orthofix Medical, Inc. | $2,869 | Research payment | Cash or cash equivalent | M6-C Artificial Cervical Disc Device, PROSTHESIS, INTERVERTEBRAL DISC | M6-C IDE | 2019 |
| 2019-10-10 | Canon Medical Systems USA, Inc. | $875 | Charitable Contribution | Cash or cash equivalent | Device, Multiple | 2019 | |
| 2019-10-10 | Canon Medical Systems USA, Inc. | $875 | Charitable Contribution | Cash or cash equivalent | Device, Multiple | 2019 | |
| 2019-10-10 | Canon Medical Systems USA, Inc. | $875 | Charitable Contribution | Cash or cash equivalent | Device, Multiple | 2019 | |
| 2019-10-10 | Canon Medical Systems USA, Inc. | $875 | Charitable Contribution | Cash or cash equivalent | Device, Multiple | 2019 | |
| 2019-10-10 | Abbott Laboratories | $297 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-10-09 | Teva Pharmaceuticals USA, Inc. | $1,000 | Research payment | Cash or cash equivalent | Ajovy Drug, Central Nervous System | A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double Blind, Placebo Controlled, Parallel Group Study, Including | 2019 |
| 2019-10-07 | Synthes GmbH | $500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-10-07 | BioFire Diagnostics, LLC | $15 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-02 | Paragon 28, Inc. | $377 | Research payment | In-kind items and services | 3D Motion Analysis of Adjacent Joint Motion After Sequential Partial Midfoot Fusion | 2019 | |
| 2019-10-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-10-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-09-30 | EXACTECH, INC. | $417,723 | Royalty or License | Cash or cash equivalent | OPTETRAK Device, ORTHOPAEDIC | 2019 | |
| 2019-09-30 | Abbott Laboratories | $4,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-09-30 | Abbott Laboratories | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-09-27 | Smith+Nephew, Inc. | $1,215 | Research payment | Cash or cash equivalent | Oxinium Hips Device, Recon Hips | A Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub | 2019 |
| 2019-09-25 | Corin USA | $6,000 | Research payment | Cash or cash equivalent | COC | 2019 | |
| 2019-09-25 | Teva Pharmaceuticals USA, Inc. | $1,512 | Research payment | Cash or cash equivalent | Ajovy Drug, Central Nervous System | A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double Blind, Placebo Controlled, Parallel Group Study, Including | 2019 |
| 2019-09-23 | AstraZeneca UK Limited | $2,016 | Research payment | Cash or cash equivalent | The purpose of this study is to evaluate the efficacy and safety of an intravenous treatment regimen of anifrolumab vers | 2019 | |
| 2019-09-20 | GE HEALTHCARE | $1,698 | Grant | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-09-19 | UOC USA INC | $1,925 | Consulting Fee | Cash or cash equivalent | U-Motion II Device, UOC Hip Sytstem | 2019 | |
| 2019-09-18 | Zimmer Biomet Holdings, Inc. | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-09-17 | Arthrex, Inc. | $5,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-09-13 | Ortho Development Corporation | $564 | Royalty or License | Cash or cash equivalent | Spinal Rod Device, ORTHOPEDIC DEVICE | 2019 | |
| 2019-08-29 | Stryker Corporation | $21,920 | Research payment | Cash or cash equivalent | REJUVENATE Device, HIPS | CLINICAL AND RADIOGRAPHIC OUTCOME OF THE STRYKER REJUVENATE MODULAR STEMS | 2019 |
| 2019-08-29 | Stryker Corporation | $4,335 | Research payment | Cash or cash equivalent | TRIATHLON Device, KNEES | ALIGNMENT AND CLINICAL OUTCOMES OF ROBOTIC ARM ASSISTED TOTAL KNEE ARTHROPLASTY | 2019 |
| 2019-08-29 | Stryker Corporation | $4,335 | Research payment | Cash or cash equivalent | TRIATHLON Device, KNEES | ALIGNMENT AND CLINICAL OUTCOMES OF ROBOTIC ARM ASSISTED TOTAL KNEE ARTHROPLASTY | 2019 |
| 2019-08-28 | Abbott Laboratories | $525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-08-28 | Abbott Laboratories | $293 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-08-28 | Abbott Laboratories | $185 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-08-28 | Abbott Laboratories | $129 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-08-27 | Synthes GmbH | $6,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-08-26 | Smith+Nephew, Inc. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Legion Revision Device, Recon Knees | 2019 | |
| 2019-08-22 | Abbott Laboratories | $1,630 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-08-22 | Stryker Corporation | $1,200 | Research payment | Cash or cash equivalent | RESTORATION Device, HIPS | RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP | 2019 |
| 2019-08-22 | Stryker Corporation | $875 | Research payment | Cash or cash equivalent | RESTORATION Device, HIPS | RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP | 2019 |
| 2019-08-22 | Stryker Corporation | $875 | Research payment | Cash or cash equivalent | RESTORATION Device, HIPS | RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP | 2019 |
| 2019-08-22 | Stryker Corporation | $875 | Research payment | Cash or cash equivalent | RESTORATION Device, HIPS | RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP | 2019 |
| 2019-08-21 | Teva Pharmaceuticals USA, Inc. | $4,500 | Research payment | Cash or cash equivalent | Ajovy Drug, Central Nervous System | A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double Blind, Placebo Controlled, Parallel Group Study, Including | 2019 |
| 2019-08-19 | PFIZER INC. | $6,125 | Research payment | Cash or cash equivalent | A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 | 2019 | |
| 2019-08-15 | Wright Medical Technology, Inc. | $20,039 | Research payment | Cash or cash equivalent | CLINICAL EXTREMITIES Device, CLINICAL EXTREMITIES | GRIP 2 STUDY | 2019 |
| 2019-08-15 | Medical Device Business Services, Inc. | $2,288 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-08-15 | Arthrex, Inc. | $2,000 | Research payment | Cash or cash equivalent | ARTHROPLASTY IMPLANTS KNEE & HIP ARTHROPLASTY TOTAL KNEE Device, ARTHROPLASTY | SOS Total Knee Arthroplasty Registry | 2019 |
| 2019-08-15 | Medical Device Business Services, Inc. | $1,497 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-08-15 | Orthofix Medical, Inc. | $1,434 | Research payment | Cash or cash equivalent | M6-C Artificial Cervical Disc Device, PROSTHESIS, INTERVERTEBRAL DISC | M6-C IDE | 2019 |
| 2019-08-15 | Zimmer Biomet Holdings, Inc. | $1,300 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-15 | Zimmer Biomet Holdings, Inc. | $1,150 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-15 | Medical Device Business Services, Inc. | $1,018 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-08-15 | Medical Device Business Services, Inc. | $1,010 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-08-15 | Medical Device Business Services, Inc. | $980 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-08-15 | Zimmer Biomet Holdings, Inc. | $531 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-15 | Medical Device Business Services, Inc. | $487 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-08-15 | Zimmer Biomet Holdings, Inc. | $419 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-15 | Zimmer Biomet Holdings, Inc. | $394 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-15 | Zimmer Biomet Holdings, Inc. | $306 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-15 | Ortho Development Corporation | $257 | Royalty or License | Cash or cash equivalent | Spinal Rod Device, ORTHOPEDIC DEVICE | 2019 | |
| 2019-08-14 | Stryker Corporation | $324 | Research payment | Cash or cash equivalent | X3 ADVANCED BEARING TECHNOLOGY Device, HIPS | RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP | 2019 |
| 2019-08-12 | EXACTECH, INC. | $5,116 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VANTAGE Device, ORTHOPAEDIC | 2019 | |
| 2019-08-08 | Stryker Corporation | $21,920 | Research payment | Cash or cash equivalent | REJUVENATE Device, HIPS | CLINICAL AND RADIOGRAPHIC OUTCOME OF THE STRYKER REJUVENATE MODULAR STEMS | 2019 |
| 2019-08-08 | Linvatec Corporation | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-08-08 | Stryker Corporation | $3,326 | Research payment | Cash or cash equivalent | SECUR-FIT Device, HIPS | SECURFIT ADVANCED OUTCOMES STUDY | 2019 |
| 2019-08-08 | Stryker Corporation | $875 | Research payment | Cash or cash equivalent | RESTORATION Device, HIPS | RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP | 2019 |
| 2019-08-08 | Stryker Corporation | $875 | Research payment | Cash or cash equivalent | RESTORATION Device, HIPS | RESTORATION ANATOMIC DUAL MOBILITY ADM X3 ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE II HIP | 2019 |
| 2019-08-08 | Stryker Corporation | $636 | Research payment | Cash or cash equivalent | TRITANIUM Device, HIPS | TRIDENT II TRITANIUM OUTCOMES STUDY | 2019 |
| 2019-08-07 | PFIZER INC. | $7,800 | Research payment | Cash or cash equivalent | A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 | 2019 | |
| 2019-08-02 | Smith+Nephew, Inc. | $17,374 | Research payment | Cash or cash equivalent | Oxinium Hips Device, Recon Hips | A Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub | 2019 |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $8,750 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $6,281 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $3,729 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $3,638 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $3,606 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | KCI USA, Inc. | $3,435 | Research payment | Cash or cash equivalent | PREVENA Device, NON-COVERED | KCI.PREVENA.2017.01 Post-market, Randomized, Open-Label, Multicenter, Study to Evaluate the Effectiveness of Closed Inci | 2019 |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $3,010 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Stryker Corporation | $2,422 | Grant | Cash or cash equivalent | NONE Device, NONE | 2019 | |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $2,232 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $924 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Stryker Corporation | $500 | Research payment | Cash or cash equivalent | TRITANIUM Device, HIPS | TRIDENT II TRITANIUM OUTCOMES STUDY | 2019 |
| 2019-07-23 | Orion Corporation | $18,746 | Research payment | Cash or cash equivalent | Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS | 2019 | |
| 2019-07-19 | Smith+Nephew, Inc. | $1,755 | Research payment | Cash or cash equivalent | Oxinium Hips Device, Recon Hips | A Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub | 2019 |
| 2019-07-18 | Stryker Corporation | $6,727 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MAKO Device, KNEES, HIPS | 2019 | |
| 2019-07-18 | Stryker Corporation | $3,627 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MAKO Device, KNEES, HIPS | 2019 | |
| 2019-07-16 | Smith+Nephew, Inc. | $2,610 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Coblation Wands Device, Sports Med Resection | 2019 | |
| 2019-07-15 | Synthes GmbH | $30,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-07-11 | Abbott Laboratories | $162 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-07-10 | GE HEALTHCARE | $200,024 | Research payment | Cash or cash equivalent | Device, MAGNETIC RESONANCE | DEVELOPMENT OF TECHNOLOGY TO EXTEND SCOPE OF MRI IN ORTHOPEDICS | 2019 |
| 2019-07-10 | PFIZER INC. | $7,800 | Research payment | Cash or cash equivalent | A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 | 2019 | |
| 2019-07-10 | Ortho Development Corporation | $1,071 | Royalty or License | Cash or cash equivalent | Spinal Rod Device, ORTHOPEDIC DEVICE | 2019 | |
| 2019-07-02 | SANOFI-AVENTIS U.S. LLC | $42,113 | Research payment | Cash or cash equivalent | SYNVISC-ONE Device, OSTEOARTHRITIS | A Study of Hyaluronan (Synvisc) for the Treatment of Osteoarthritis in the Thumb: Randomized Clinical Trial | 2019 |
| 2019-07-02 | Cumberland Pharmaceuticals, Inc. | $11,354 | Research payment | Cash or cash equivalent | CPI-IFE -004 SSc | 2019 | |
| 2019-07-02 | Smith+Nephew, Inc. | $4,000 | Research payment | Cash or cash equivalent | REDAPT Revision Hip System Device, Recon Hips | REDAPT 17 Monolithic Stems | 2019 |
| 2019-07-01 | Wright Medical Technology, Inc. | $18,000 | Research payment | Cash or cash equivalent | CLINICAL EXTREMITIES Device, CLINICAL EXTREMITIES | GRIP 2 STUDY | 2019 |
| 2019-07-01 | Smith+Nephew, Inc. | $726 | Research payment | Cash or cash equivalent | REDAPT Revision Hip System Device, Recon Hips | REDAPT 17 Monolithic Stems | 2019 |
| 2019-06-30 | EXACTECH, INC. | $455,658 | Royalty or License | Cash or cash equivalent | OPTETRAK Device, ORTHOPAEDIC | 2019 | |
| 2019-06-28 | Regeneron Pharmaceuticals, Inc. | $103,463 | Research payment | Cash or cash equivalent | 2019 | ||
| 2019-06-28 | EXACTECH, INC. | $17,510 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EQUINOXE Device, ORTHOPAEDIC | 2019 | |
| 2019-06-27 | Lima USA, Inc. | $6,208 | Education | In-kind items and services | Promade Device, Devices | 2019 | |
| 2019-06-27 | Medartis Inc. | $2,000 | Grant | Cash or cash equivalent | APTUS Device, ORTHO | 2019 | |
| 2019-06-27 | Stryker Corporation | $1,560 | Research payment | Cash or cash equivalent | RESTORIS Device, HIPS | OUTCOMES OF ROBOTIC ASSISTED UNICOMPARTMENTAL KNEE ARTHROPLASTY, A LARGE SINGLE CENTER STUDY | 2019 |
| 2019-06-27 | Abbott Laboratories | $988 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-06-27 | Abbott Laboratories | $567 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-06-27 | Stryker Corporation | $500 | Research payment | Cash or cash equivalent | TRIDENT Device, HIPS | THE NEW SURGEON TIME UTILIZATION AND RADIOGRAPHIC ACCURACY IN ROBOTICARM ASSISTED ANTERIOR AND POSTERIOR TOTAL HIP ARTHR | 2019 |
| 2019-06-26 | UOC USA INC | $1,700 | Consulting Fee | Cash or cash equivalent | U-Motion II Device, UOC Hip System | 2019 | |
| 2019-06-25 | BioFire Diagnostics, LLC | $7,029 | Research payment | Cash or cash equivalent | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2019 |
| 2019-06-24 | Medtronic USA, Inc. | $15,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MazorX - Renaissance Device, Enabling | 2019 | |
| 2019-06-24 | Baxter Healthcare | $3,500 | Education | Cash or cash equivalent | ACTIFUSE Device, Surgical Care | 2019 | |
| 2019-06-24 | Medtronic USA, Inc. | $3,191 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MazorX - Renaissance Device, Enabling | 2019 | |
| 2019-06-19 | Stryker Corporation | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CASCADIA Device, SPINE | 2019 | |
| 2019-06-17 | Medline Industries LP | $4,974 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 |
The latest 200 records of 367.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Paramus, NJ, county Bergen County, NJ, state New Jersey; placed by its city name.
| Measure | Place (city or town) Paramus, NJ | County Bergen County, NJ | State New Jersey |
|---|---|---|---|
| Population B01003 | 26,568 | 962,316 | 9,343,809 |
| Population, 2020 census P1 | 26,698 | 955,732 | 9,288,994 |
| Median age B01002 | 49.1 | 42.0 | 40.1 |
| Under 18 B01001 | 18.5% | 20.9% | 21.8% |
| 65 and over B01001 | 26.2% | 18.2% | 17.2% |
| Households B11001 | 8,464 | 355,127 | 3,507,701 |
| Foreign born B05002 | 31.3% | 31.8% | 23.9% |
| Median household income B19013 | $144,349 | $124,884 | $103,556 |
| Median family income B19113 | $159,496 | $152,200 | $127,025 |
| Per capita income B19301 | $58,552 | $63,735 | $54,253 |
| Poverty rate B17001 | 4.7% | 6.8% | 9.7% |
| Unemployment rate B23025 | 7.7% | 5.8% | 6.3% |
| Civilian labor force B23025 | 13,348 | 527,974 | 5,003,179 |
| Mean commute (minutes) B08013 | 30.8 | 31.2 | 30.5 |
| Bachelor's degree or higher B15003 | 51.8% | 53.1% | 43.6% |
| Housing units B25001 | 8,813 | 369,613 | 3,791,354 |
| Owner-occupied B25003 | 82.6% | 65.3% | 63.8% |
| Renters B25003 | 17.4% | 34.7% | 36.2% |
| Median home value B25077 | $813,900 | $623,000 | $454,400 |
| Median gross rent B25064 | $3,032 | $1,914 | $1,720 |
| White, not Hispanic B03002 | 54.1% | 51.3% | 50.9% |
| Black B03002 | 4.1% | 5.4% | 12.2% |
| Hispanic or Latino B03002 | 13.0% | 22.7% | 22.5% |
| Asian B03002 | 25.7% | 16.8% | 10.0% |
| American Indian and Alaska Native B03002 | 0.6% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Paramus, NJ.
Comments